Prevalence and characteristics of adverse drug reactions in neurosurgical intensive care patients

Neurosurgery
Kelly M SmithJimmi Hatton

Abstract

To evaluate the prevalence and characteristics of adverse drug reactions (ADRs) in neurosurgical intensive care patients. Retrospective analysis of ADR data obtained from a spontaneous reporting system in a tertiary care university hospital. Reports of suspected ADRs in adult patients admitted emergently or electively to the neurosurgical service were included. Over the 3 year period, 3496 neurosurgical intensive care unit (ICU) patient admissions accounted for 5% of all hospital admissions. A total of 10% of all neurosurgical patients developed a suspected ADR, with three patients experiencing multiple reactions. Other adult ICU patients developed ADRs at a comparable rate (9%, P > 0.05). Overall, neurosurgery patients accounted for 12% of all spontaneously reported ADRs. Preventable reactions were observed in 43 (13%) cases, and treatment was required for 76%. The majority (96%) of ADRs resolved or improved at the time of the ADR report. Nausea, pruritus, thrombocytopenia, and vomiting were most frequently noted. Therapies most often associated with reported events were analgesics, antipyretics, antibiotics, anticonvulsants, and histamine H2 antagonists. The relationship between central nervous system disease and adverse even...Continue Reading

References

Nov 27, 1991·JAMA : the Journal of the American Medical Association·D C ClassenJ P Burke
Sep 1, 1988·Journal of Neurosurgery·A B YoungC J McClain
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Feb 15, 1995·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jun 1, 1994·Annals of Internal Medicine·E M Hylek, D E Singer
Jan 22, 1997·JAMA : the Journal of the American Medical Association·D C ClassenJ P Burke
Mar 1, 1997·The Annals of Pharmacotherapy·S D HanesB A Boucher
Jan 22, 1998·The New England Journal of Medicine·R S EvansJ P Burke
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Oct 24, 1998·Clinical Pharmacokinetics·B A Boucher, S D Hanes
May 14, 1999·European Journal of Drug Metabolism and Pharmacokinetics·P PappasM Marselos
Jul 28, 1999·JAMA : the Journal of the American Medical Association·L L LeapeD W Bates
Jan 6, 2001·The Annals of Pharmacotherapy·D C SuhE R Hermes-De Santis
Feb 15, 2001·Journal of Clinical Anesthesia·D J CullenUNKNOWN Adverse Drug Event Prevention Study Group
Apr 23, 2002·Intensive Care Medicine·Emily E WadeFrederick B Rogers
Sep 27, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Almut G WintersteinRichard Segal
Mar 15, 2003·The New England Journal of Medicine·Charles Vincent
Aug 2, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Eyal OrenB Joseph Guglielmo
Sep 25, 2003·Archives of Internal Medicine·Suzan N KucukarslanDaniel A Nafziger
Apr 28, 2004·Archives of Internal Medicine·Jonathan RosandSteven M Greenberg
Mar 15, 2005·Clinical Pharmacokinetics·Shufeng ZhouHoward L McLeod
May 25, 2005·Archives of Internal Medicine·Anne M HolbrookPhilip S Wells
May 25, 2005·Archives of Internal Medicine·Jonathan R NebekerJohn F Hurdle
Jun 11, 2005·Chest·Allan Garland
Mar 29, 2008·Clinical Drug Investigation·E VargasA Moreno

❮ Previous
Next ❯

Citations

Jun 9, 2012·Pharmacoepidemiology and Drug Safety·Antonio Pintor-MármolMaria José Faus
Nov 28, 2013·Pharmacotherapy·A Shaun RoweUNKNOWN Neurocritical Care Society Pharmacy Section
Aug 21, 2013·Seminars in Hematology·Thomas ThieleTamam Bakchoul
Aug 20, 2014·British Journal of Neurosurgery·Imran NooraniPaul Grundy
Sep 21, 2013·British Journal of Hospital Medicine·Colin Bigham, Alison Elsey
May 6, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kelly M SmithSony Tuteja
Aug 29, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Anastasia Rivkin
Oct 27, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nakyung JeonAlmut G Winterstein
Nov 19, 2010·Postgraduate Medicine·Richard PushkinStephanie Kim
Oct 7, 2021·European Journal of Clinical Pharmacology·O LaatikainenM Turpeinen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.